Results 191 to 200 of about 6,658 (202)

Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors

Clinical Pharmacology in Drug Development, 2019
Patricia M. Lorusso, Jim J Xiao, Rebecca Kristeleit   +2 more
exaly  

Rucaparib (Rubraca®)

Oncology Times, 2017
openaire   +1 more source

Imaging PARP with F-18-rucaparib

Journal of Nuclear Medicine, 2021
Chan, Chung Ying, Chen, Zijun, Destro, Gianluca, Veal, Mathew, Lau, Doreen, O'Neill, Edward, Dias, Gemma, Mosley, Michael, Guibbal, Florian, Gouverneur, Veronique, Cornelissen, Bart   +10 more
openaire   +1 more source

NICE decisions on rucaparib and atezolizumab

PharmacoEconomics & Outcomes News, 2019
openaire   +1 more source

IMPROVED PREPARATION METHOD FOR RUCAPARIB

2023
CHEON CHEOL-HONG, PARK JINJAE
openaire   +1 more source

NOVEL METHOD FOR PREPARING RUCAPARIB

2023
CHEON CHEOL-HONG, PARK JINJAE
openaire   +1 more source

Identification of Differential Biological Activity and Synergy Between the PARP Inhibitor Rucaparib and Its Major Metabolite

Cell Chemical Biology
Albert Antolín Santaliestra, Amadeu Llebaria, Alvaro Aytes   +2 more
exaly  

SOLID STATE FORMS OF RUCAPARIB TOSYLATE

2023
ŠKALEC ŠAMEC DIJANA, TRAVANČIĆ VALENTINA, ŠAHNIĆ DAMIR   +2 more
openaire   +1 more source

METHODS AND INTERMEDIATES FOR PREPARING RUCAPARIB

2019
JAYACHANDRA SURESHBABU, SETHI MADHURESH, KAUSHIK VIPIN KUMAR, RAVI VIJAYA, TELAGAMSETTY BHASKAR KUMAR   +4 more
openaire   +1 more source

PROCESS FOR THE PREPARATION OF RUCAPARIB AND NOVEL SYNTHESIS INTERMEDIATES

2019
BECK BRENT CHRISTOPHER, PERALES JOE B, SPEAKE JASON D, FERRANDO ILARIA   +3 more
openaire   +2 more sources